AVITA Medical, Inc.

NASDAQ:RCEL

Medical - Devices

Healthcare
$16.83 -0.25%

+$0.00 today

Market cap
$418.11M
Beta
1.86
P/E (TTM)
-0.0
EPS (TTM)
-$148.45
52W Low $3.22High $7.12

Volume 0.72M

Average 0.24M

RCEL Other Current Assets

Current assets not reported separately, such as prepaid expenses.

AVITA Medical, Inc.NASDAQ: RCEL

Other Current Assets · Q1 FY2026 · quarter ended Mar 2026

Other current assets falls 13.8% from a year ago

Other current assets stood at $1.38M at the end of Q1 FY2026, down 13.8% from a year earlier and up 8.8% from the prior quarter. Over 3 fiscal years it compounded at +52.9% a year.

Context

  • Other current assets amounted to 2.7% of total assets at the end of Q1 FY2026, up 0.4 pp from a year earlier.
  • Other current assets increased in 1 of the last 3 fiscal years.

What to watch

Whether other current assets keeps falling in the next quarterly balance sheet after a -13.8% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$1.38M+8.8% QoQ
Last fiscal yearDec 2025
$1.29M-31.3% YoY
Year agoMar 2025
$1.61M-13.8% since
Other Current Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-13.8%——
1 year-31.3%——
3-year CAGR+52.9%——
5-year CAGR——
10-year CAGR——

Other Current Assets history

USD · from the balance sheet

Latest · FY2025
1.29M USD
Year-over-year change
-31.3%
4-year CAGR
+45.3%

Other Current Assets vs competitors

How RCEL compares with its peers on the latest reported figures

  • RCEL's Mar 2026 other current assets of $1.38M is the 8th highest of the 9 companies compared; the peer median is $2.1M.
  • Its year-over-year change of -13.8% is the 5th highest of 7, against a peer median of -8.7%.
  • Other current assets amounts to 2.7% of total assets for RCEL, versus a peer median of 2.7%.
RCEL Competitors Peer median
Other Current Assets for RCEL and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
OVIDOvid Therapeutics Inc.Mar 2026$4.62M —+27406.7%2.0%
STTKShattuck Labs, Inc.Mar 2026$3.33M -39.4%-42.6%3.3%
HYPRHyperfine, Inc.Mar 2026$3.13M -8.0%-6.1%5.2%
FONRFONAR CorporationMar 2026$2.41M +1.5%—1.1%
VANIVivani Medical, Inc.Mar 2026$1.79M +7.2%—4.2%
LUCDLucid Diagnostics Inc.Mar 2026$1.49M ——4.4%
XTNTXtant Medical Holdings, Inc.Mar 2026$1.4M -23.0%+146.0%1.8%
RCELAVITA Medical, Inc.Mar 2026$1.38M -13.8%+52.9%2.7%
APYXApyx Medical CorporationMar 2026$1.37M -9.5%-20.9%2.2%
Peer median (excluding RCEL) $2.1M-8.7%-6.1%2.7%

Competitors are the stored peer set for RCEL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents55.51M18.16M22.12M14.05M10.24M
Short-term Investments29.65M61.18M66.94M21.84M7.94M
Net Receivables3.43M4.96M7.92M11.96M9.09M
Inventory2.13M2.13M5.6M7.27M6.93M
Other Current Assets290K362K18K1.88M1.29M
Total Current Assets92.13M87.46M104.01M57M35.49M
Property, Plant & Equipment (Net)2.81M2.05M4.32M13.59M11.53M
Goodwill00000
Intangible Assets443K465K487K5.57M5.65M
Long-term Investments19.69M6.93M000
Tax Assets00000
Other Non-current Assets942K1.36M2.83M3.55M3.73M
Total Non-current Assets23.88M10.81M7.63M22.71M20.9M
Total Assets116.02M98.26M111.64M79.71M56.39M
Account Payables2.71M3M3.79M6.29M8.96M
Short-term Debt000042.98M
Tax Payables00000
Deferred Revenue0033K00
Other Current Liabilities355K456K506K2.51M9.81M
Total Current Liabilities9.15M10.69M13.2M20.16M62.68M
Long-term Debt0039.81M42.25M0
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)0698K357K324K290K
Other Non-current Liabilities1.33M1.83M7.51M9.65M7.94M
Total Non-current Liabilities2.25M2.83M49.39M55.05M10.37M
Total Liabilities11.39M13.52M62.58M75.21M73.04M
Common Stock3K3K3K3K(1.29M)
Retained Earnings(235.92M)(262.59M)(297.97M)(359.81M)(408.4M)
Accumulated OCI8.06M7.63M(1.89M)(1.94M)(1.37M)
Other Stockholders Equity0(127K)(1.13M)(1.32M)0
Minority Interest00000
Total Equity104.62M84.74M49.06M4.5M(16.65M)
Total Debt1.64M918K42.41M45.99M46.05M
Net Debt(53.87M)(17.25M)20.29M31.94M35.81M

AVITA Medical, Inc.

NASDAQ:RCEL

Intrinsic Alpha fair value

Locked

Current Price

$16.83

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.